Financial Highlights:
• Revenue grew 13.3% to £279.6m (2016: £246.7m); 1.7% at constant fx
• Trading profit* increased 37.1% to £29.2m (2016: £21.3m); 18.2% at constant fx
• Trading profit* margins further improved to 10.4% (2016: 8.6%)
• Adjusted earnings per share** increased 39.6% to 14.8p (2016: 10.6p)
• Basic earnings per share of 11.6p (2016: 4.1p)
• Net debt of £16.1m (March 2016: £2.6m) after paying US$35m (£28.3m) for the acquisition of EuroMed
• Final dividend increased 14.3% to 2.0p (2016: 1.75p)